ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,893Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 403

$1.01M Total Retail Price of All Prescriptions

Rank: 6 out of 403

612 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 612 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 612 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 11,502 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 627 496 1 2
LISINOPRIL 577 496 2 1
AMLODIPINE BESYLATE 507 479 3 4
HYDROCHLOROTHIAZIDE 456 408 4 6
LEVOTHYROXINE SODIUM 431 336 5 3
METOPROLOL SUCCINATE 409 350 6 11
METOPROLOL TARTRATE 338 301 7 10
OMEPRAZOLE 332 252 8 9
METFORMIN HCL 331 252 9 8
ATORVASTATIN CALCIUM 317 273 10 5
FUROSEMIDE 296 236 11 7
CRESTOR 278 215 12 19
ZETIA 228 180 13 59
WARFARIN SODIUM 226 204 14 12
HYDROCODONE-ACETAMINOPHEN 206 153 S3 15 15
DIGOXIN 201 179 16 56
ALENDRONATE SODIUM 199 148 17 26
ENALAPRIL MALEATE 191 162 18 66
LOSARTAN POTASSIUM 185 144 19 21
ZOLPIDEM TARTRATE 161 123 20 16
TRAMADOL HCL 157 144 21 28
TAMSULOSIN HCL 155 128 22 27
NEXIUM 155 123 22 18
RAMIPRIL 153 123 24 75
POTASSIUM CHLORIDE 140 120 25 37
GABAPENTIN 135 106 26 17
PRAVASTATIN SODIUM 127 120 27 14
TRAZODONE HCL 118 91 28 25
SERTRALINE HCL 118 78 28 20
CYMBALTA 117 49 30 43
DIOVAN 116 115 31 24
GLIMEPIRIDE 111 91 32 61
QUINAPRIL HCL 109 100 33 67
BUSPIRONE HCL 104 88 34 206
MIRTAZAPINE 93 56 35 38
OXYCONTIN 93 71 S2 35 63
CLOPIDOGREL 93 76 35 55
OXYCODONE HCL 90 37 S2 38 39
ADVAIR DISKUS 86 59 39 33
FLUOXETINE HCL 86 86 39 57
TRICOR 86 58 39 90
OXYCODONE-ACETAMINOPHEN 82 38 S2 42 45
PAROXETINE HCL 80 80 43 68
KLOR-CON 10 79 75 44 218
PANTOPRAZOLE SODIUM 78 64 45 30
PHENYTOIN SODIUM EXTENDED 78 42 45 166
CITALOPRAM HBR 76 60 47 22
ALLOPURINOL 75 62 48 31
EVISTA 73 73 49 106
ATENOLOL 73 73 49 13
PROAIR HFA 72 55 51 40
LOVAZA 70 43 52 105
WELCHOL 69 49 53 187
CARVEDILOL 69 57 53 32
SPIRIVA 68 61 55 35
BUPROPION HCL SR 64 14 56 125
GLIPIZIDE 63 50 57 70
ISOSORBIDE MONONITRATE ER 62 50 58 62
OLANZAPINE 61 18 59 77
GLIPIZIDE ER 59 56 60 86
JANUVIA 58 33 61 44
PLAVIX 56 47 62 83
VERAPAMIL ER 53 53 63 98
ACTOS 53 40 63 95
LANTUS SOLOSTAR 53 25 63 80
DIVALPROEX SODIUM ER 53 14 63 152
DILTIAZEM 24HR CD 53 40 63 102
NASONEX 52 43 68 139
DOXYCYCLINE HYCLATE 51 28 69 147
LOVASTATIN 50 44 70 42
NIASPAN 50 24 70 142
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.